Sixteen years ago, Alfred Molina’s Doctor Octopus gave Tobey Maguire’s Peter Parker the fight of a lifetime in Spider-Man 2. Regardless of Doc Ock’s apparent demise in the movie, Alfred Molina is reportedly set to reprise his role as Otto Octavius in the next MCU Spider-Man movie.
According to The Hollywood Reporter, sources have confirmed Molina’s return. THR also notes that GWW reportedly spotted on set last month. To date, Molina is the only actor to portray Doc Ock in the live-action movies. He will also be the second actor to reprise his role from the original Spider-Man trilogy, following J.K. Simmons’ J. Jonah Jameson.
Jamie Foxx is also set to return as Electro, following his turn in Amazing Spider-Man 2. The presence of Spider-Man villains from two different timelines has sparked speculation that the new movie will explore the multiverse. Collider is also reporting that Andrew Garfield and Kirsten Dunst will be back as Peter Parker/Spider-Man and Mary Jane Watson, respectively. Collider also claims that Maguire is in negotiations to return, while Emma Stone’s appearance as Gwen Stacy may be determined by her pregnancy. However, no major Hollywood outlet has confirmed Collider’s report at this time.
RELATED: Tom Holland Confirms That Spider-Man 3 Has Started Filming
Spider-Man: Homecoming and Spider-Man: Far From Home director Jon Watts will close out the new trilogy. Zendaya, Marisa Tomei, Jacob Batalon, and Tony Revolori will also return for the sequel. Additionally, Benedict Cumberbatch’s Doctor Strange will be the key MCU guest star in this film.
The next MCU Spider-Man film will hit theaters on December 17, 2021. However, that date may change.
How do you feel about the return of Alfred Molina’s Doctor Octopus? Let us know in the comment section below!
Recommended Reading: Spider-Man: Far From Home – The Art of the Movie
We are also a participant in the Amazon Services LLC Associates Program. This affiliate advertising program also provides a means to earn fees by linking to Amazon.com and affiliated sites.